N/A
N=86
ENB-GS-TBLB for the Diagnosis of PPLs
Lung Cancer
Bottom Line
View on ClinicalTrials.gov: NCT02207478 ↗Enrolled (actual)
86
Serious AEs
0.0%
Results posted
Nov 2015
Primary outcome: Primary: The Difference of Diagnostic Value of ENB-GS-TBLB as Compared to GS-TBLB — 34; 25; 5; 16 participants — p=0.019
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- ENB (Procedure); GS-TBLB-X-ray (Procedure)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Shanghai Chest Hospital
- Primary completion
- Mar 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Difference of Diagnostic Value of ENB-GS-TBLB as Compared to GS-TBLB |
34; 25; 5; 16 | 0.019 sig |
| SECONDARY The Duration Time Difference of ENB-GS-TBLB With Fluoroscopy as Compared to GS-TBLB With Fluoroscopy Alone |
1053.6; 1056.6; 156.56; 142.27; 126.74; 224.98 | 0.843 |
Summary
The purpose of this study is to evaluate the efficacy and safety of electromagnetic navigation bronchoscopy with a Guide Sheath(ENB-GS) for the diagnosis of peripheral pulmonary lesions (PPLs) .
Eligibility Criteria
Inclusion Criteria
- clinical and imaging characteristics suggestive of maligancy
- CT scan appearance of the PPLs showed the longest diameter was more than 1 cm and solid lesions.
Exclusion Criteria
- The lesion is close to the pleural membrane
- Refusal of participation
- Severe cardiopulmonary dysfunction and other indications that can't receive bronchoscopy
Data sourced from ClinicalTrials.gov (NCT02207478). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.